Advertisement Fidelity
Home > Boards > US OTC > Medical - Drugs >

Cellceutix Corporation (CTIX)

Add CTIX Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator BigKahuna, tamtam9042, KarinCA, noretreat, TOB, starbuxsux
Search This Board:
Last Post: 4/23/2014 5:54:29 AM - Followers: 423 - Board type: Free - Posts Today: 4

Cellceutix Corporation (CTIX)

Company Address:
100 Cumming Center, Suite 151-B
Beverly, MA 01915
Phone: 978-236-8717
Fax:  978-921-6564
CIK:  0001355250
Cellceutix is a publicly traded company under the symbol “CTIX”. Cellceutix is a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology and antibiotic applications. Cellceutix believes it has a world-class portfolio of compounds and is now engaged in advancing its compounds and seeking strategic partnerships. Cellceutix’s anti-cancer drug Kevetrin is currently in a Phase 1 clinical trial at Harvard Cancer Centers’ Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center. In the laboratory Kevetrin has shown to induce activation of p53, often referred to as the “Guardian Angel Gene” due to its crucial role in controlling cell mutations. Cellceutix is planning a Phase 2 clinical trial with its novel compound Brilacidin-OM for the prevention and treatment of Oral Mucositis. Brilacidin-OM, a defensin mimetic compound, has shown in the laboratory to reduce the occurrence of severe ulcerative oral mucositis by more than 94% compared to placebo. Cellceutix’s anti-psoriasis drug Prurisol is presently in a bioequivalence crossover clinical trial in Miami, FL. Prurisol is a small molecule that acts through immune modulation and PRINS reduction. Cellceutix’s key antibiotic, Brilacidin, is in a Phase 2b trial for Acute Bacterial Skin and Skin Structure Infections, or ABSSSI. Brilacidin has the potential to be a single-dose therapy or a dosing regimen that is shorter than currently marketed antibiotics for multi-drug resistant bacteria (Superbugs). Cellceutix has formed research collaborations with world-renowned research institutions in the United States and Europe, including MD Anderson Cancer Center, Beth Israel Deaconess Medical Center, and the University of Bologna.


Ongoing Human Trials:
Product Pipeline:

Recent News and Press Releases:
SEC Filings:

Transfer Agent:
West Coast Stock Transfer, Inc.
721 N. Vulcan Ave. Ste. 205
Encinitas, CA 92024
(619) 664-4780 p
(760) 452-4423 f

Share Structure:  See SEC filing link above for current share structure
Investor Relations:


All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
CTIX News: Study Shows Cellceutix Antibiotic Active Against Drug-Resistant Superbug Klebsiella Pneumoniae 04/14/2014 06:30:00 AM
CTIX News: Cellceutix Comments on Positive FDA Advisory Vote for Dalbavancin and Tedizolid 04/01/2014 08:00:00 AM
CTIX News: Cellceutix Initiates Clinical Trial of Prurisol as New Treatment for Psoriasis 03/25/2014 06:00:00 AM
CTIX News: Cellceutix to Initiate Psoriasis Clinical Trial 03/21/2014 06:00:00 AM
CTIX News: Seventh Cohort Underway in Cellceutix Clinical Trial of Kevetrin for Solid Tumors 03/19/2014 08:40:37 AM
#57289  Sticky Note Cellceutix Initiates Clinical Trial of Prurisol as New starbuxsux 03/25/14 09:02:21 AM
#56404  Sticky Note Presentation: Daniel Jorgensen, MD, MPH, Infectious Disease Specialist BigKahuna 03/13/14 05:30:43 PM
#53467  Sticky Note Here is my bottom line on Brilacidin for TheProgressive 02/03/14 07:20:54 PM
#52072  Sticky Note Cellceutix Sees Increased Valuation Potential for Its Novel starbuxsux 01/21/14 09:22:28 AM
#51541  Sticky Note Very impressive and positive CTIX PR and presentation! TOB 01/15/14 02:41:11 PM
#39163  Sticky Note $CTIX News, SEC filings, FDA trials, misc., and chart: KarinCA 08/25/13 03:20:25 PM
#58791   If the mtd were to be at least noretreat 04/23/14 05:54:29 AM
#58790   Phase 1 results are always released shortly after alexander77 04/23/14 02:06:37 AM
#58789   215 dgjared 04/23/14 02:06:24 AM
#58788   Reading the tea leaves: I Need Help 04/23/14 01:07:27 AM
#58787   I guess its nice... 123tom 04/22/14 10:23:47 PM
#58786   I think we could see a run to ericseb2003 04/22/14 10:14:56 PM
#58785   Even if MTD is at 220mg (Cohort-8 level) cabel 04/22/14 08:13:10 PM
#58784   I would also prefer that. And, that is BigKahuna 04/22/14 08:03:41 PM
#58783   Not me. cabel 04/22/14 07:58:56 PM
#58782   I would like to see mtd well above noretreat 04/22/14 07:52:01 PM
#58781   But we suffer PPS when they have to eventhelosers 04/22/14 06:01:00 PM
#58780   Excellent, thanks for the details BK oddone33320 04/22/14 04:44:58 PM
#58779   Because there are so few patients enrolled in BigKahuna 04/22/14 04:19:22 PM
#58778   I agree BK. as much as we'd love TheProgressive 04/22/14 04:12:05 PM
#58777   That second paragraph explains something I could not DoubleJ23 04/22/14 04:07:52 PM
#58776   First there is the dose limiting toxicity (DLT) BigKahuna 04/22/14 04:03:44 PM
#58775   Tomorrow it will be 5 weeks since they cabel 04/22/14 03:58:05 PM
#58774   Thanks cabel much appreciated! oddone33320 04/22/14 03:42:06 PM
#58773   BK can give you the exact definition but cabel 04/22/14 03:38:49 PM
#58772   248 vip1999 04/22/14 03:38:44 PM
#58771   Wow! Bid $1.62 Ask $1.69 ctix 04/22/14 03:35:46 PM
#58770   hahaha..YEP ! : ) wild4ctix 04/22/14 03:33:33 PM
#58769   Could someone please explain how a MTD is oddone33320 04/22/14 03:29:11 PM
#58768   210?! Is that all you got? :) Tails 04/22/14 03:22:42 PM
#58767   If cohort 8 is approved, the likely dose BigKahuna 04/22/14 03:15:15 PM
#58764   210... GO CTIX ! wild4ctix 04/22/14 03:08:15 PM
#58762   BK, While we're waiting what's your guess on how cabel 04/22/14 03:04:38 PM
#58761   Yay! Over 1.60 again, if only for the moment. BigKahuna 04/22/14 02:58:06 PM
#58760   Great day today for CTIX! smitter 04/22/14 02:13:32 PM
#58759   Need a push in volume to cut through BooDog 04/22/14 01:28:38 PM
#58758   Thanks cabel. Good post. eom tootalljones 04/22/14 01:17:18 PM
#58757   oddone, you may be right, but I believe 58nout 04/22/14 12:53:18 PM
#58756   A bit more volume coming in now. cabel 04/22/14 11:21:26 AM
#58755   Nice Early morning Vol here! smitter 04/22/14 10:43:33 AM
#58754   Looks like the Bio-Tech Sector is rebounding nicely! cabel 04/22/14 10:26:28 AM
#58753   LOL i am waiting for one of LEO's govorchin 04/22/14 10:26:24 AM
#58752   Hey gov! cabel 04/22/14 10:18:57 AM
#58751   lol. posted my last buy rec @ 1.52 BooDog 04/22/14 10:18:48 AM
#58750   waiting for SPORE grant. don't know if govorchin 04/22/14 10:14:29 AM
#58749   Prurisol competition....can anyone tell from the description below Chemdeps 04/22/14 10:09:27 AM
#58748   My guess is that their sentiment is similar oddone33320 04/22/14 10:09:04 AM
#58747   Your post was very short compared to some TheDane 04/22/14 10:07:05 AM
#58746   BK where is that in writing? Just curious thanks tombrady12nh 04/22/14 10:00:32 AM
#58745   Not always the case,... look how bright Polymedex was! cabel 04/22/14 09:37:43 AM
#58744   Doesn't make me wonder. CTIX management is already BigKahuna 04/22/14 09:34:56 AM
#58743   Hmmmmm makes you wonder about K doesn't it? tombrady12nh 04/22/14 09:27:07 AM
#58742   I wonder why, when Pfizeer is looking for cabel 04/22/14 09:24:15 AM
#58741   Cancer pipeline drugs the focus in deal making Matagordaville 04/22/14 09:02:00 AM
#58740   I was kinda wondering myself lol. Not BooDog 04/22/14 06:11:12 AM
#58738   Positive ctix! Apparition 04/22/14 12:08:09 AM